Class IITerminatedD-1308-2019
Drug recall · June 5, 2019
Bevacizumab 2.5 mg/0.1 mL recall
Why: Lack of assurance of sterility
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Bevacizumab 2.5 mg/0.1 mL, packaged in a Prefilled Syringe, Rx only, AVELLA SPECIALTY PHARMACY 24416 N. 19TH AVENUE PHOENIX, AZ 85085, NDC 42852-001-27
- Lots / codes
Lot #: 138-20191202@64, Exp 05/13/19
- Quantity
- 730 syringes
- Company
- Avella of Deer Valley, Inc. Store 38, Phoenix, AZ
- Distribution
- U.S.A. nationwide
- Initiated
- May 3, 2019 · Voluntary: Firm initiated
- Classified
- May 29, 2019
- Reported
- June 5, 2019
- Ended
- February 25, 2020
- How notified
- Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.